BlessFeedHealth, food and lifestyle releases

Press Release · NCPDP

NCPDP Announces Leadership Transition and Promotion of J.W. Hill to President & COO

Distributed by BlessFeed · Originally issued via PR Newswire

SCOTTSDALE, Ariz., Nov. 16, 2026 — NCPDP announced today the promotion of J.W. Hill, MBAHCM, AAiP its current Chief Operating Officer to President & COO as part of the organization's long-standing and strategic executive succession plan.

National Council for Prescription Drug Programs (NCPDP) logo

Since 2017, NCPDP's Board of Trustees and executive leadership have maintained a transparent succession strategy focused on ensuring long-term organizational continuity, operational stability, and sustained industry leadership. The current COO originally joined NCPDP as EVP & General Manager with the understanding that the role would support long-term succession planning and executive leadership development under the mentorship of Lee Ann Stember.

Over the past several years, the COO has played a critical leadership role in advancing NCPDP's strategic initiatives, operational modernization, standards acceleration efforts, industry engagement, and organizational growth. In the role of COO, Hill has overseen day-to-day operations while helping NCPDP to address the evolving needs of healthcare interoperability, standards development, electronic prior authorization, API strategy, patient access, and emerging technologies such as artificial intelligence.

The promotion to President & COO represents the next phase in NCPDP's transition planning as the current CEO prepares for retirement as communicated on November 11 by June 1, 2027.

"This transition reflects years of thoughtful planning and leadership development designed to ensure continuity for our members, staff, partners, and the healthcare industry," said Lee Ann Stember, CEO of NCPDP. "The promotion to President & COO recognizes the significant leadership contributions already being made and positions the organization for a seamless future transition."

As President & COO, Hill will continue overseeing organizational operations while assuming expanded strategic and external leadership responsibilities in partnership with the CEO during the transition period.

"NCPDP has been incredibly intentional in preparing for the future," said Hill. "I am honored by the trust placed in me by Lee Ann and the NCPDP Board and remain committed to advancing NCPDP's mission, supporting our members, and continuing to strengthen the role our standards play in improving healthcare interoperability and patient care."

NCPDP remains focused on advancing healthcare interoperability through standards development, collaboration, innovation, and industry leadership that supports patients, providers, pharmacies, payers, and healthcare technology partners nationwide.

SOURCE NCPDP

About NCPDP

The National Council for Prescription Drug Programs (NCPDP), established in 1977, is a nonprofit ANSI-accredited Standards Developer (ASD) with members across the healthcare industry. NCPDP develops standards and solutions to improve the exchange of information for medications, supplies, and services, including the SCRIPT Standard for ePrescribing and the Telecommunication Standard. Its data products include dataQ®, providing insights on over 80,000 pharmacies, and HCIdea®, a prescriber database with over 3.7 million records. NCPDP's RxReconn® offers real-time tracking of pharmacy-related legislative and regulatory activity at state and national levels. Named in federal legislation such as HIPAA and HITECH, NCPDP has been advancing healthcare interoperability for decades. Learn more at www.ncpdp.org.